Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 117654
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117654
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117654
Figure 1 Flow of hepatocellular carcinoma recruitment for the retrospective study.
HCC: Hepatocellular carcinoma.
Figure 2 Aetiological risk factors for hepatocellular carcinoma cases.
MASLD: Metabolic-associated steatotic liver disease; HCV: Hepatitis C virus; HBV: Hepatitis B virus.
Figure 3 Clinical symptoms of hepatocellular carcinoma cases.
RUQ: Right upper quarter.
Figure 4 Kaplan-Meier survival curves.
A: Child-Pugh scores; B: Barcelona Clinic Liver Cancer stage; C: Performance status of the patients. BCLC: Barcelona Clinic Liver Cancer.
- Citation: Musa Y, Dankiri NA, Saleh HT, Onyia CP, Abdulkareem LO, Okonkwo KC, Abdulkareem FB, Shu'aibu RB, Aminu AS, Ewa AM, Abdullahi HZ, Njideka AW, Sunusi HI, Ijoma UN, Sunday NV, Chukwudike ES, Okeke UF, Asogwa PU, Mukoro GD, Abdullahi MK, Odeghe EA, Nwoko C, Takwashe IM, Oguntoye OO, Owoseni OO, Jimoh AO, Oyeleke GK. Assessing hepatocellular carcinoma in Nigeria: A multicenter retrospective cohort review of prevalence, risk factors, and treatment outcomes. World J Gastrointest Oncol 2026; 18(5): 117654
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/117654.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.117654